| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT07602907 Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A… |
Recruitment opened |
| 2026-08-12 | NCT07602907 Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A… |
Primary endpoint(s) modified |
| 2026-08-12 | NCT07602907 Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A… |
Enrollment increased: 44 -> 73 participants |
| 2026-08-12 | NCT07602907 Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A… |
Trial arms changed: 3 -> 5 |
| 2026-08-12 | NCT07602907 Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A… |
date change Primary completion pushed: 2029-05-07 -> 2029-08-20 |
| 2026-08-12 | NCT07602907 Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A… |
date change Completion pushed: 2029-05-07 -> 2029-08-20 |
| 2026-08-08 | NCT07162714 SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer |
Recruitment opened |
| 2026-08-08 | NCT07162714 SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer |
date change Primary completion pushed: 2026-06-30 -> 2027-03-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05148767 | UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | Rectal Cancer Stage III | Recruiting |
| Phase 3 | |||
| NCT04974346 | Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer | Cervical Cancer | Recruiting |
| NCT06214195 | The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related… | Cardiotoxicity Induced by Drug Therapy for Breast Cancer | Recruiting |
| NCT06609551 | ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer… | Colon Cancer | Recruiting |
| NCT07235930 | Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG… | Non-Resectable Pancreas Carcinoma | Recruiting |
| NCT07074353 | Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer | Locally Advanced Rectal Cancer | Not Yet Recruiting |
| NCT07691515 | Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus… | Intrahepatic Cholangiocarcinoma (Icc) | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06911086 | SH-LPS System in Preoperative Planning for Liver Resection | Liver Tumor; Surgery | Not Yet Recruiting |
| Phase 2 | |||
| NCT05075512 | The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced… | Breast Neoplasm Female | Recruiting |
| NCT05507411 | Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT05514275 | Radiotherapy Combined With Endostatin and Capecitabine for NPC | Nasopharyngeal Carcinoma | Recruiting |
| NCT05652192 | SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC | Advanced Nasopharyngeal Carcinoma | Recruiting |
| NCT05992597 | ZR2 Sequential Immunochemotherapy for Newly Treated MCL | Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma | Recruiting |
| NCT06055816 | Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally… | Nasopharyngeal Carcinoma | Recruiting |
| NCT06190639 | A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT06086197 | A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL | Diffuse Large B-cell Lymphoma Recurrent | Recruiting |
| NCT06272214 | Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy | Adjuvant Radiotherapy | Recruiting |
| NCT06413342 | Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal… | Esophageal Cancer | Recruiting |
| NCT06562920 | Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of… | Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer | Recruiting |
| NCT06674096 | RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL | Double-expressor Lymphoma | Recruiting |
| NCT06292689 | A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or… | Vulvar and Vaginal Cancer | Recruiting |
| NCT06538896 | Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced… | Triple-negative Breast Cancer | Recruiting |
| NCT05557578 | GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors… | Intrahepatic Cholangiocarcinoma | Recruiting |
| NCT05920863 | Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the… | Hepatocellular Carcinoma | Recruiting |
| NCT07014410 | Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and… | Breast Cancer | Recruiting |